Abstract:The aim of this study was to develop and test an optimal vaccination strategy against bovine viral diarrhea virus (BVDV) based on the E2 glycoprotein of the BJ1305 strain. To achieve higher E2-specific antibody titers and to broaden the cellular immune response, a plasmid encoding the E2 protein (pcDNA3.1-E2) was constructed and a purified recombinant E2 protein was generated. The E2 protein was emulsified in the adjuvant ISA 61 VG prior to administration. We immunized mice three times with pcDNA3.1-E2 or the recombinant E2 protein or primed twice with pcDNA3.1-E2 and boosted once with the E2 protein. To evaluate the protection against BVDV conferred by the vaccines, the mice were challenged with BVDV strain Oregon C24V after the third immunization. Although all immunized mice developed humoral and cellular immune responses, the E2-specific antibody titers in the DNA prime-protein boost group were significantly higher than those elicited by either the DNA or the protein vaccine. In addition, vaccination with the E2 DNA vaccine induced higher percentages of CD4(+)IFN-gamma(+) T cells and CD8(+)IFN-gamma(+) T cells among total CD3(+) T cells than the other regimens. The predominant antibody subclass in the vaccinated mice was IgG1. Serum tumor necrosis factor alpha (TNE-alpha) levels in the DNA prime-protein boost group were significantly higher after the third immunization than in the other groups. Moreover, the mice treated with the DNA prime-protein boost vaccination regimen acquired protection against BVDV challenge, as shown by a significant reduction of viremia, only minor pathological changes, and a lower viral antigen burden than in the control and solo vaccinated mice. These results demonstrate the potential advantage of a DNA prime-protein boost vaccination approach over a solo vaccination for the prevention of BVDV. The ability of this vaccine strategy to control and eradicate BVD in herds warrants further investigation. (C) 2018 Elsevier Ltd. All rights reserved.

Combination Immunization with EIAV Env Protein Expressed by Recombinant Baculovirus and Recombinant Vaccinia Virus Containing Env Gene

Combined immunity of DNA vector and recombinant vaccinia virus expressing Gag proteins of equine infectious anemia virus

[Expression and Immunogenicity of Equine Infectious Anemia Virus Membrane Protein GP90].

A Pilot Study Comparing the Development of EIAV Env-Specific Antibodies Induced by DNA/Recombinant Vaccinia-Vectored Vaccines and an Attenuated Chinese EIAV Vaccine

A Pilot Study on an Attenuated Chinese EIAV Vaccine Inducing Broadly Neutralizing Antibodies

Construction and Immunogenicity of Recombinant Expression Vectors of Western Equine Encephalomyelitis Virus

Immunogenicity evaluation of recombinant<i>Lactobacillus casei</i>W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant

Broader HIV-1 Neutralizing Antibody Responses Induced by Envelope Glycoprotein Mutants Based on the EIAV Attenuated Vaccine

Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant

Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV

Baculovirus Surface Display of E Envelope Glycoprotein of Japanese Encephalitis Virus and Its Immunogenicity of the Displayed Proteins in Mouse and Swine Models.

Experimental immunization of mice with a recombinant bovine enterovirus vaccine expressing BVDV E0 protein elicits a long-lasting serologic response

Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two Viruses

An Attenuated EIAV Vaccine Strain Induces Significantly Different Immune Responses from Its Pathogenic Parental Strain Although with Similar in Vivo Replication Pattern

[Induction of EIAV-specific Cellular Immune Response by Attenuated EIAV Vaccine].

Immunization with Pseudotype Baculovirus Expressing Envelope Protein of Japanese Encephalitis Virus Elicits Protective Immunity in Mice

Enhanced Immune Responses to E2 Protein and DNA Formulated with ISA 61 VG Administered As a DNA Prime–protein Boost Regimen Against Bovine Viral Diarrhea Virus

A Recombinant Rabies Virus Expressing Echinococcus Granulosus EG95 Induces Protective Immunity in Mice.

Virus-like particles vaccines based on glycoprotein E0 and E2 of bovine viral diarrhea virus induce Humoral responses

Construction and Immunogenicity Analysis of a Vaccine Against HIV-1 AE Recombinant

Amino Acid Mutations in the Env Gp90 Protein That Modify N-linked Glycosylation of the Chinese EIAV Vaccine Strain Enhance Resistance to Neutralizing Antibodies.